Invention Grant
- Patent Title: Compounds that are ERK inhibitors
-
Application No.: US16032715Application Date: 2018-07-11
-
Publication No.: US10759805B2Publication Date: 2020-09-01
- Inventor: Jongwon Lim , Xianhai Huang , Ronald D. Ferguson , Wei Zhou , Christopher W. Boyce , Phieng Siliphaivanh , David J. Witter , Milana M. Maletic , Joseph A. Kozlowski , Kevin J. Wilson
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Jeffrey P. Bergman; Catherine D. Fitch
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D471/14 ; C07D519/00 ; C07D487/04
Abstract:
Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (I).
Public/Granted literature
- US20180319804A1 NOVEL COMPOUNDS THAT ARE ERK INHIBITORS Public/Granted day:2018-11-08
Information query
